These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 7524521)

  • 1. The CD19/CD21 signal transduction complex of B lymphocytes.
    Tedder TF; Zhou LJ; Engel P
    Immunol Today; 1994 Sep; 15(9):437-42. PubMed ID: 7524521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
    Bradbury LE; Kansas GS; Levy S; Evans RL; Tedder TF
    J Immunol; 1992 Nov; 149(9):2841-50. PubMed ID: 1383329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex.
    Fearon DT; Carroll MC
    Annu Rev Immunol; 2000; 18():393-422. PubMed ID: 10837064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
    Luxembourg AT; Cooper NR
    J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.
    Fearon DT; Carter RH
    Annu Rev Immunol; 1995; 13():127-49. PubMed ID: 7542009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD20: a regulator of cell-cycle progression of B lymphocytes.
    Tedder TF; Engel P
    Immunol Today; 1994 Sep; 15(9):450-4. PubMed ID: 7524522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13.
    Bradbury LE; Goldmacher VS; Tedder TF
    J Immunol; 1993 Sep; 151(6):2915-27. PubMed ID: 7690791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system.
    Tedder TF; Poe JC; Fujimoto M; Haas KM; Sato S
    Curr Dir Autoimmun; 2005; 8():55-90. PubMed ID: 15564717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.
    Sato S; Miller AS; Howard MC; Tedder TF
    J Immunol; 1997 Oct; 159(7):3278-87. PubMed ID: 9317126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
    Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
    J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-structural determinants of immunogenicity and the B cell co-receptors, CD19, CD21, and CD22.
    Fearon DT
    Adv Exp Med Biol; 1998; 452():181-4. PubMed ID: 9889972
    [No Abstract]   [Full Text] [Related]  

  • 12. The B lymphocyte as an immunotherapeutic target.
    Fearon DT
    QJM; 1995 Mar; 88(3):149-53. PubMed ID: 7539331
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of lymphocyte activation by the cell-surface molecule CD22.
    Law CL; Sidorenko SP; Clark EA
    Immunol Today; 1994 Sep; 15(9):442-9. PubMed ID: 7945784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.
    Rickert RC
    Curr Opin Immunol; 2005 Jun; 17(3):237-43. PubMed ID: 15886112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD24 antigen discriminates between pre-B and B cells in human bone marrow.
    Duperray C; Boiron JM; Boucheix C; Cantaloube JF; Lavabre-Bertrand T; Attal M; Brochier J; Maraninchi D; Bataille R; Klein B
    J Immunol; 1990 Dec; 145(11):3678-83. PubMed ID: 1700990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjögren's syndrome.
    Smith AJ; Gordon TP; Macardle PJ
    Tissue Antigens; 2004 Mar; 63(3):255-9. PubMed ID: 14989715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes.
    Matsumoto AK; Martin DR; Carter RH; Klickstein LB; Ahearn JM; Fearon DT
    J Exp Med; 1993 Oct; 178(4):1407-17. PubMed ID: 7690834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.
    Boackle SA; Morris MA; Holers VM; Karp DR
    J Immunol; 1998 Dec; 161(12):6537-43. PubMed ID: 9862679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.
    Zouali M; Sarmay G
    Arthritis Rheum; 2004 Sep; 50(9):2730-41. PubMed ID: 15457440
    [No Abstract]   [Full Text] [Related]  

  • 20. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice.
    Rickert RC; Rajewsky K; Roes J
    Nature; 1995 Jul; 376(6538):352-5. PubMed ID: 7543183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.